AstraZeneca bets on new cancer treatments with US$2 billion Fusion Pharma purchase
ASTRAZENECA said on Tuesday (Mar 19) it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals for about US$2 billion in cash ...
ASTRAZENECA said on Tuesday (Mar 19) it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals for about US$2 billion in cash ...
ON THE first anniversary of UBS Group’s historic takeover of its former rival Credit Suisse, it is becoming clear just ...
CHINA’S central bank has approved Tencent Holdings’ online payment platform Tenpay boosting its registered capital to 15.3 billion yuan (S$2.8 ...
FRANCE’S billionaire Saadé family has agreed to buy Patrick Drahi’s Altice Media, including French news channel BFM TV, for a ...
CHINA’S ByteDance-owned TikTok posted revenue of about US$16 billion last year in the United States, where the viral video app ...
SWISSCOM said on Friday (Mar 15) it will buy Vodafone Italia for US$8.70 billion and merge the business with its ...
THE United States plans to award more than US$6 billion to Samsung Electronics, helping the chipmaker expand beyond a project ...
CISCO Systems won unconditional EU antitrust approval for its US$28 billion bid for cybersecurity firm Splunk on Wednesday (Mar 14) ...
DRUGMAKER AstraZeneca said on Thursday (Mar 14) it would acquire rare endocrine diseases-focused firm Amolyt Pharma for US$1.05 billion in ...
A SHARP correction in small-cap stocks portends souring risk appetite on the broader Indian market, which is now an underperformer ...
International Business Weekly is an American entertainment magazine. We cover business News & feature exclusive interviews with many notable figures